Fig. 2From: Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsGrowth of expert curated variants (3Â month rolling average). The curated variants that were reported (pale lines) represent 69.1% average of all curated variants. All curated variants (solid lines) are comprised of clinically reported variants, benign, likely benign and variants of unknown significanceBack to article page